
Core Insights - Adient (ADNT) reported adjusted earnings per share (EPS) of 45 cents for Q3 FY2025, an increase from 32 cents year-over-year but below the Zacks Consensus Estimate of 47 cents [1][9] - The company generated net sales of $3.74 billion, reflecting a 0.7% year-over-year increase and exceeding the Zacks Consensus Estimate of $3.56 billion [1][9] - Adient raised its revenue guidance for FY2025 to $14.4 billion from a previous estimate of $13.9 billion, with adjusted EBITDA also increased to $875 million from $850 million [7][9] Segment Performance - The Americas segment reported revenues of $1.76 billion, up 1.3% year-over-year, surpassing the Zacks Consensus Estimate of $1.59 billion, with adjusted EBITDA of $112 million, an increase from $99 million in the prior year [3] - The EMEA segment generated revenues of $1.27 billion, down 1.6% year-over-year but above the Zacks Consensus Estimate of $1.22 billion, with adjusted EBITDA declining to $21 million from $25 million [4] - The Asia segment's revenues were $721 million, slightly up from $712 million year-over-year but below the Zacks Consensus Estimate of $739 million, with adjusted EBITDA increasing to $113 million from $101 million [5] Financial Position - As of June 30, 2025, Adient had cash and cash equivalents of $860 million, down from $945 million as of September 30, 2024, and long-term debt stood at $2.39 billion [6] - Capital expenditures for the quarter totaled $57 million, compared to $70 million in the prior-year quarter [6] Guidance Updates - Adient's updated guidance for FY2025 includes projected revenues of $14.4 billion, adjusted EBITDA of $875 million, equity income of $75 million, and free cash flow anticipated in the range of $150-$170 million, with capital expenditures estimated at $260 million [7]